Steven Block - Ambu AS CEO USA

AMBU-B Stock  DKK 111.00  3.20  2.80%   

Insider

Steven Block is CEO USA of Ambu AS
Age 60
Phone45 72 25 20 00
Webhttps://www.ambu.com

Ambu AS Management Efficiency

The company has return on total asset (ROA) of 0.0141 % which means that it generated a profit of $0.0141 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0236 %, meaning that it generated $0.0236 on every $100 dollars invested by stockholders. Ambu AS's management efficiency ratios could be used to measure how well Ambu AS manages its routine affairs as well as how well it operates its assets and liabilities.
Ambu AS has accumulated 1.25 B in total debt with debt to equity ratio (D/E) of 63.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Ambu AS has a current ratio of 2.7, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Ambu AS until it has trouble settling it off, either with new capital or with free cash flow. So, Ambu AS's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ambu AS sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ambu to invest in growth at high rates of return. When we think about Ambu AS's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Gry LarsenBioPorto
N/A
Anthony PareBioPorto
60
EjvindgensencBrain AS
N/A
Sren KjrulffChemoMetec AS
N/A
Michael PackertChemoMetec AS
N/A
Lars UttenthalBioPorto
N/A
Kristine FaerchChemoMetec AS
N/A
Niels KristensencBrain AS
N/A
Steen SondergaardChemoMetec AS
64
MBA MScOrphazyme AS
53
Tony SummerlincBrain AS
N/A
Jennifer McCannOrphazyme AS
N/A
Christopher RunchelChemoMetec AS
N/A
Neil CPABioPorto
55
Christopher BirdBioPorto
N/A
Martin BehrensChemoMetec AS
N/A
Nis KruseBioPorto
N/A
Niels NielsenChemoMetec AS
N/A
Jennifer ZondermanBioPorto
N/A
Lisbet HellesChemoMetec AS
N/A
Christopher MScChemoMetec AS
N/A
Ambu AS provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics in Europe, North America, and internationally. The company was founded in 1937 and is headquartered in Ballerup, Denmark. Ambu AS operates under Medical Devices classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 2700 people. Ambu AS (AMBU-B) is traded on Copenhagen Exchange in Denmark and employs 4,500 people.

Management Performance

Ambu AS Leadership Team

Elected by the shareholders, the Ambu AS's board of directors comprises two types of representatives: Ambu AS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ambu. The board's role is to monitor Ambu AS's management team and ensure that shareholders' interests are well served. Ambu AS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ambu AS's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Schmidt, Ex CFO
Henrik Ankjr, Ex Operations
Thomas Henriksen, Head Systems
Anders Williamsson, Managing Director
Nicolai Thomsen, Director Planning
Mikkel Wagner, Director Communications
Bassel Rifai, Chief VP
Steven Block, CEO USA
Mns Barsne, Ex Officer
Britt Jensen, Chief Officer

Ambu Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ambu AS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Ambu AS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ambu AS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ambu AS will appreciate offsetting losses from the drop in the long position's value.

Moving against Ambu Stock

  0.67VIRO ViroGates ASPairCorr
  0.57MAERSK-B AP MllerPairCorr
  0.56MAERSK-A AP MllerPairCorr
The ability to find closely correlated positions to Ambu AS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ambu AS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ambu AS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ambu AS to buy it.
The correlation of Ambu AS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ambu AS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ambu AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ambu AS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Ambu Stock

Ambu AS financial ratios help investors to determine whether Ambu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ambu with respect to the benefits of owning Ambu AS security.